Drugs & Treatments - malecare.org

Degarelix Proves to be the Superior Hormone Deprivation Treatment (ADT) for Men with Advanced Prostate Cancer

Based on six recent retrospective analyses comparing the gonadotropin-releasing hormone (GnRH) antagonist degarelix against the traditional luteinizing hormone-releasing hormone (LHRH) agonists (i.e. Zoladex, Lupron etc.) men with advanced prostate cancer experienced improved disease control, fewer instances of urinary infections, and a lower risk of cardiovascular events. The six analyses compared data from randomized trials that [...]

By Malecare|2017-10-19T10:49:17-04:00November 5th, 2013|Advanced Prostate Cancer, Drugs & Treatments, Firmagon (degarelix), Hormone Therapy, Research, Uncategorized, Understanding APC|2 Comments

Bone Disease in Men with Prostate Cancer Needs Constant Monitoring

The number of cancer survivors is increasing, soon to be as many of 13 million of us in the world! Bones are often affected in cancer survivors, usually a result of bone metastases, or of anti-cancer therapies which can contribute to bone loss and fragility. Bone disease in cancer survivors can result both from the [...]

By Malecare|2013-11-04T20:25:00-05:00November 4th, 2013|Advanced Prostate Cancer, bisphosphonates, Bone Metastases, Bone Mineral Density, denosumab - Xgeva, Drugs & Treatments, General Information, Hormone Therapy, Quality of Life, Uncategorized, Understanding APC, Zometa|0 Comments

Why Xofigo is Superior to Other Radiopharmaceuticals for Advanced Prostate Cancer Treatment

We are in the fortunate position because the treatment of men with metastatic castration-resistant prostate cancer (mCRPC) continues to evolve as new agents with the ability to extend survival gain FDA approval. The most recently FDA approved treatment, the alpha emitting radiopharmaceutical radium-223 (Xofigo) was approved for men with bone metastatic prostate cancer. Most other [...]

By Malecare|2013-10-31T13:13:04-04:00October 31st, 2013|Advanced Prostate Cancer, Alpha Emitting Radio Therapy, Alpharadin (radium-223), Bone Metastases, Clinical Trials, Clinical Trials, Drugs & Treatments, radiopharmaceuticals, Uncategorized, Understanding APC, Xofigo|8 Comments

Is Zytiga with Prednisone Effective in Men with Metastatic Prostate Cancer Who Have Visceral Disease?

Castate resistant metastatic prostate cancer (mRPC) withvisceral disease (tumors involving the internal organs of the body, specifically those within the chest (as the heart or lungs) or abdomen (as the liver, pancreas or intestines) is a negative prognostic factor. In many cases clinical trials of new investigational drugs rule out men with visceral disease from [...]

By Malecare|2017-10-19T10:49:21-04:00October 29th, 2013|abiraterone acetate, Advanced Prostate Cancer, Clinical Trials, Clinical Trials, Drugs & Treatments, Quality of Life, Research, Uncategorized, Understanding APC, Zytiga|0 Comments

To Stay Alive Avoid the Hospital on Weekends and Night Time If Possible

In prior posts I have strongly recommended that, if possible, it is in your best interest not to go into the hospital in the month of July. The month of July is the traditional beginning of a new rotation for the new hospital Residents, or there are an overwhelming number of newly minted doctors with [...]

By Malecare|2020-02-04T11:50:38-05:00October 25th, 2013|Advanced Prostate Cancer, Drugs & Treatments, General Information, How We Live, Politics of Cancer, Uncategorized|0 Comments